(Q42244955)

English

Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration

scientific article published on February 1, 1981

Statements

Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration (English)
Treatment of Huntington disease with -acetylenic GABA, an irreversible inhibitor of GABA- transaminase: Increased CSF GABA and homocarnosine without clinical amelioration (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit